openPR Logo
Press release

Uveitis Therapeutics Analysis, Clinical Trials and Developments by Key Players Aldeyra Therapeutics, EyeGate Pharma (Nasdaq:EYEG), EyePoint Pharmaceuticals

12-06-2018 09:36 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Uveitis Therapeutics Analysis, Clinical Trials

The study analyzed that the uveitis therapeutics pipeline comprises 33 drug candidates in different stages of development.

Uveitis is a type of inflammatory disease that causes swelling and destroys eye tissues. Occurrence of this disease can result in slight reduction of vision or lead to complete vision loss. Uveitis occurs when the middle layer of the eyeball gets inflamed (red and swollen). This layer, known as the uvea, has many blood vessels that nourish the eye. Uveitis can damage vital eye tissue, even resulting in permanent vision loss.

Download report sample at: https://www.psmarketresearch.com/market-analysis/uveitis-therapeutics-pipeline-analysis/report-sample

*Durasert technology platform for Uveitis drug development

pSivida Corp. is using durasert technology platform for the development of Medidur for the treatment of uveitis. This technology platform is used to provide sustained, localized delivery of drugs to the back of the eye. Durasert products are developed with a drug core surrounded with one or more polymer layers, the permeability of those layers and other aspects of the design of the product, controls the rate and duration of the drug release. However, changing the elements of the design, can help in altering both the rate and duration of release to meet different therapeutic needs. The later generation durasert products and product candidates are injected at the target site, while early generations were surgically implanted.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=uveitis-therapeutics-pipeline-analysis

*Various companies received grants for the development of Uveitis Therapeutics Pipeline

Many companies are involved in the development of drugs for the uveitis therapeutics pipeline, with their products in different phases.

Browse report at: https://www.psmarketresearch.com/market-analysis/uveitis-therapeutics-pipeline-analysis

Some of the key players developing drugs for the treatment of uveitis include Aldeyra Therapeutics, Inc., EyeGate Pharmaceuticals, Inc., pSivida Corp. and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Therapeutics Analysis, Clinical Trials and Developments by Key Players Aldeyra Therapeutics, EyeGate Pharma (Nasdaq:EYEG), EyePoint Pharmaceuticals here

News-ID: 1423370 • Views: 566

More Releases from P&S Intelligence

New feature of Female Fertility and Pregnancy Rapid Test Market Size, Strategies …
The global market is increasing, due to growing female geriatric population and increasing incidence of uterine malformations. In addition, the growing female infertility cases, increasing cases with abnormal uterine bleeding and growing demand for easy to use at home diagnostic devices are encouraging the growth of the global female fertility and pregnancy rapid test market. Explore Full Report on “Female fertility and pregnancy rapid test Market” at: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market The information and data
Disposable Medical Sensors Market Insights, Potential Business Strategies, Merge …
The disposable medical sensors market is witnessing a trend of home healthcare services due to the rising healthcare costs and incidence of hospital-acquired infections. Technological advancements have played a major role in improving the diagnostics field by giving rise to its subset, point-of-care diagnosis. Portable devices for home healthcare use sensors for the detection of specified parameters and offer immediate results. The key manufacturing companies are increasingly investing in light
Bottled Water Market Professional Survey Report, Industry Growth, Shares, Market …
Drinking water packed in glass or plastic bottles is referred as bottled water. Bottled water may or may not be carbonated. Bottled water continues to be a popular choice of consumers despite the carbonated soft drinks having established. Water sold in large bottles holding one to 2.5 gallons is relatively cheaper compared to carbonated water sold at higher prices per gallon. Increasing inclination of consumers from high calorie carbonated soft
Aquaculture Market Outlook, Opportunities, Challenges, Trends, Size and Growth, …
Aquaculture involves cultivation of brackish water, marine water, and freshwater organisms such as carps, crustaceans, mollusks and salmon, under organized climatic conditions. It involves the farming of fish and other aquatic species. The global aquaculture market is segmented on the basis of culture environment, and product.. On the basis of culture environment, the global aquaculture market can be segmented into freshwater, marine water, and brackish water. The market by product segment

All 5 Releases


More Releases for Uveitis

Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market to Perceive Substantial Growth by 2024
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and
Global Uveitis market Research Report - Pipeline Review, H2 2017
"The Latest Research Report Uveitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Uveitis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis-Pipeline Review, H2 2017, provides an overview of the Uveitis (Ophthalmology) pipeline landscape. Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis